FDA Announces Approval of Biosimilar User Fee Cover Sheet Collection

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information related to the Biosimilar User Fee Cover Sheet, as required by the Paperwork Reduction Act of 1995, which is administered by the FDA and can be submitted via the FDA's website at https://www.fda.gov/